View all available purchase options and get full access to this article. The following represents disclosure information provided by authors of this manuscript. All relationships are considered ...

Our foray into causal analysis is not yet complete. Until we define the methods of causal inference, we can't get to the deeper insights that causal analysis can provide. This article details many of ...

BOSTON, Oct. 24, 2023 /PRNewswire/ -- PhaseV a pioneer in causal machine learning (ML) technology that optimizes clinical trial design and analysis, announced today that it has raised $15 million in ...

Pharma commercial operating models rely on clinically testing many compounds to approve a single blockbuster that recoups all investments. The challenge for drug development is that clinical efficacy ...

"I read it as a joke!" one student chortled. "It definitely wasn't completely serious, was it?" another asked as she shook her head in disbelief. The intimate group of nine students—which includes a ...

A study from Columbia University  reports a major advance in understanding how interactions between human and viral genomes shape disease risk. The research found that variations in the Epstein–Barr ...

Led by Prysm Capital and Accenture with participation from Silver Lake Waterman, Liquid 2 Ventures, NextEquity, Friends & Family Capital, and WndrCo, this round positions Alembic among the top AI labs ...